{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:02:32Z","timestamp":1771999352471,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.lungcan.2007.12.025","type":"journal-article","created":{"date-parts":[[2008,2,21]],"date-time":"2008-02-21T07:25:50Z","timestamp":1203578750000},"page":"235-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Mesothelin-related predictive and prognostic factors in malignant mesothelioma: A nested case\u2013control study"],"prefix":"10.1016","volume":"61","author":[{"given":"Oluf Dimitri","family":"Roe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenette","family":"Creaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steinar","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Sandeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Boffetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom Ivar","family":"Nilsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Kjaerheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9483","key":"10.1016\/j.lungcan.2007.12.025_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lungcan.2007.12.025_bib2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1179\/oeh.2006.12.3.248","article-title":"Banning asbestos in Asia: campaigns and strategies by the Asian Network for the Rights of Occupational Accident Victims (ANROAV)","volume":"12","author":"Pandita","year":"2006","journal-title":"Int J Occup Environ Health"},{"issue":"3","key":"10.1016\/j.lungcan.2007.12.025_bib3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1179\/oeh.2003.9.3.244","article-title":"A cross-country comparative overview of the asbestos situation in ten Asian countries","volume":"9","author":"Takahashi","year":"2003","journal-title":"Int J Occup Environ Health"},{"issue":"Suppl 1","key":"10.1016\/j.lungcan.2007.12.025_bib4","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.lungcan.2005.03.025","article-title":"Epidemic of mesothelioma in Egypt","volume":"49","author":"Gaafar","year":"2005","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2007.12.025_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2486\/indhealth.45.379","article-title":"Malignant mesothelioma: global incidence and relationship with asbestos","volume":"45","author":"Bianchi","year":"2007","journal-title":"Ind Health"},{"key":"10.1016\/j.lungcan.2007.12.025_bib6","unstructured":"Cancer in Norway 2004. Kreftregisteret, Oslo; 2005."},{"key":"10.1016\/j.lungcan.2007.12.025_bib7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ajim.10047","article-title":"Malignant Mesothelioma in Australia 1945\u20132000","volume":"41","author":"Leigh","year":"2002","journal-title":"Am J Ind Med"},{"issue":"6","key":"10.1016\/j.lungcan.2007.12.025_bib8","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1183\/09031936.96.09061206","article-title":"Malignant pleural mesothelioma from nonoccupational asbestos exposure in Metsovo (north-west Greece): slow end of an epidemic?","volume":"9","author":"Sakellariou","year":"1996","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.lungcan.2007.12.025_bib9","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1378\/chest.122.6.2224","article-title":"Malignant mesothelioma due to environmental exposure to asbestos: follow-up of a Turkish cohort living in a rural area","volume":"122","author":"Metintas","year":"2002","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.lungcan.2007.12.025_bib10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nrc947","article-title":"SV40 and human tumours: myth, association or causality?","volume":"2","author":"Gazdar","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"9254","key":"10.1016\/j.lungcan.2007.12.025_bib11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(00)04013-7","article-title":"Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey","volume":"357","author":"Roushdy-Hammady","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.lungcan.2007.12.025_bib12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1378\/chest.125.2.744","article-title":"Changing patterns in asbestos-induced lung disease","volume":"125","author":"Ohar","year":"2004","journal-title":"Chest"},{"issue":"14","key":"10.1016\/j.lungcan.2007.12.025_bib13","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.lungcan.2007.12.025_bib14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.113.3.723","article-title":"Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B","volume":"113","author":"Herndon","year":"1998","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.lungcan.2007.12.025_bib15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1053\/rmed.2001.1178","article-title":"Prognostic factors in diffuse malignant pleural mesothelioma: effects of pretreatment clinical and laboratory characteristics","volume":"95","author":"Metintas","year":"2001","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.lungcan.2007.12.025_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00420-003-0498-6","article-title":"Factors influencing long-term survival in mesothelioma patients\u2014results of the German mesothelioma register","volume":"77","author":"Neumann","year":"2004","journal-title":"Int Arch Occup Environ Health"},{"issue":"2","key":"10.1016\/j.lungcan.2007.12.025_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00001622-200303000-00002","article-title":"Predictive and prognostic factors in malignant pleural mesothelioma","volume":"15","author":"Baas","year":"2003","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"10.1016\/j.lungcan.2007.12.025_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1096-9896(1998110)186:3<300::AID-PATH180>3.0.CO;2-Q","article-title":"Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome","volume":"186","author":"Kumar-Singh","year":"1998","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.lungcan.2007.12.025_bib19","first-page":"1857","article-title":"Cyclooxygenase-2 expression is a novel prognostic factor in malignant mesothelioma","volume":"8","author":"Edwards","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.lungcan.2007.12.025_bib20","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-05-3907","article-title":"Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction","volume":"66","author":"Lopez-Rios","year":"2006","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.lungcan.2007.12.025_bib21","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1158\/1078-0432.CCR-04-2181","article-title":"Validation of genomics-based prognostic tests in malignant pleural mesothelioma","volume":"11","author":"Gordon","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.lungcan.2007.12.025_bib22","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1373\/clinchem.2006.079327","article-title":"MESOMARK: a potential test for malignant pleural mesothelioma","volume":"53","author":"Beyer","year":"2007","journal-title":"Clin Chem"},{"issue":"9396","key":"10.1016\/j.lungcan.2007.12.025_bib23","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","article-title":"Mesothelin-family proteins and diagnosis of mesothelioma","volume":"362","author":"Robinson","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.lungcan.2007.12.025_bib24","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1158\/1055-9965.EPI-05-0334","article-title":"Mesothelin variant 1 is released from tumour cells as a diagnostic marker","volume":"15","author":"Hellstrom","year":"2006","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"10.1016\/j.lungcan.2007.12.025_bib25","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1158\/1055-9965.EPI-06-0479","article-title":"Mesothelin is shed from tumor cells","volume":"15","author":"Ho","year":"2006","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"6","key":"10.1016\/j.lungcan.2007.12.025_bib26","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.hoc.2005.09.007","article-title":"Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein","volume":"19","author":"Creaney","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"issue":"10","key":"10.1016\/j.lungcan.2007.12.025_bib27","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/1078-0432.CCR-06-2144","article-title":"Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment","volume":"13","author":"Grigoriu","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.lungcan.2007.12.025_bib28","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1007\/s00330-003-1851-6","article-title":"CT findings and serum ca 125 levels in malignant peritoneal mesothelioma: report of 11 new cases and review of the literature","volume":"13","author":"Kebapci","year":"2003","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.lungcan.2007.12.025_bib29","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1378\/chest.119.4.1138","article-title":"Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma","volume":"119","author":"Paganuzzi","year":"2001","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.lungcan.2007.12.025_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000049366","article-title":"Prognostic value of serum tumor markers in patients with lung cancer","volume":"69","author":"Hatzakis","year":"2002","journal-title":"Respiration"},{"issue":"5","key":"10.1016\/j.lungcan.2007.12.025_bib31","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1097\/01.ju.0000176742.53556.25","article-title":"Serum CYFRA 21-1 in patients with invasive bladder cancer and its relevance as a tumor marker during chemotherapy","volume":"174","author":"Andreadis","year":"2005","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.lungcan.2007.12.025_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygyno.2004.07.039","article-title":"Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma","volume":"95","author":"McIntosh","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.lungcan.2007.12.025_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1097-0142(19960701)78:1<57::AID-CNCR10>3.0.CO;2-6","article-title":"Tumor markers in patients with pancreatic carcinoma","volume":"78","author":"Gattani","year":"1996","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.lungcan.2007.12.025_bib34","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1080\/10428190500204781","article-title":"Usefulness of tumor markers CA 125 and CA 15.3 at diagnosis and during follow-up in non-Hodgkin's lymphoma: study of 200 patients","volume":"46","author":"Batlle","year":"2005","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.lungcan.2007.12.025_bib35","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/sj.bjc.6602199","article-title":"BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case\u2013control study","volume":"91","author":"Bjorge","year":"2004","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.lungcan.2007.12.025_bib36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejheart.2004.07.015","article-title":"The significance of CA125 levels in patients with chronic congestive heart failure. Correlation with clinical and echocardiographic parameters","volume":"7","author":"Kouris","year":"2005","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.lungcan.2007.12.025_bib37","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1097\/00000478-200311000-00003","article-title":"Application of mesothelin immunostaining in tumor diagnosis","volume":"27","author":"Ordonez","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.lungcan.2007.12.025_bib38","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/modpathol.3800534","article-title":"Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity","volume":"19","author":"Yaziji","year":"2006","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.lungcan.2007.12.025_bib39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/01.mpa.0000160281.56828.76","article-title":"Expression of mesothelin mRNA in pure pancreatic juice from patients with pancreatic carcinoma, intraductal papillary mucinous neoplasm of the pancreas, and chronic pancreatitis","volume":"30","author":"Watanabe","year":"2005","journal-title":"Pancreas"},{"issue":"5","key":"10.1016\/j.lungcan.2007.12.025_bib40","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1158\/1078-0432.CCR-06-2161","article-title":"Mesothelin expression in human lung cancer","volume":"13","author":"Ho","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2007.12.025_bib41","unstructured":"http:\/\/www.proteinatlas.org\/."},{"issue":"10","key":"10.1016\/j.lungcan.2007.12.025_bib42","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","article-title":"Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion","volume":"279","author":"Rump","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lungcan.2007.12.025_bib43","doi-asserted-by":"crossref","unstructured":"Scholler N, Garvik B, Hayden-Ledbetter M, Kline T, Urban N. Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery. Cancer Lett; May 3, 2006.","DOI":"10.1016\/j.canlet.2006.03.029"},{"issue":"1","key":"10.1016\/j.lungcan.2007.12.025_bib44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1476-4598-5-50","article-title":"Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors","volume":"5","author":"Gubbels","year":"2006","journal-title":"Mol Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2007.12.025_bib45","first-page":"85","article-title":"Experiences of the Janus Serum Bank in Norway","volume":"103","author":"Jellum","year":"1995","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.lungcan.2007.12.025_bib46","doi-asserted-by":"crossref","unstructured":"SPLF\u2014Recommandations de la Soci\u00e9t\u00e9 de Pneumologie de Langue Fran\u00e7aise sur le m\u00e9soth\u00e9liome pleural. Paris; January 23, 2006. p. 13.","DOI":"10.1016\/S0761-8425(06)71780-6"},{"issue":"2","key":"10.1016\/j.lungcan.2007.12.025_bib47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1309\/QHCA-8594-TA7P-0DVQ","article-title":"An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma","volume":"114","author":"Brockstedt","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.lungcan.2007.12.025_bib48","unstructured":"Arbeidsdirektoratet [Directorate of Labour]. Nordisk yrkesklassifisering. Standard for yrkesgrupperinger i offentlig norsk statistikk [Nordic Classification of Occupations. Standard for classification of occupations in Norwegian statistics]. Oslo; 1965."},{"issue":"1","key":"10.1016\/j.lungcan.2007.12.025_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910580102","article-title":"Residential radon exposure and lung cancer\u2014an epidemiological study of Norwegian municipalities","volume":"58","author":"Magnus","year":"1994","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.lungcan.2007.12.025_bib50","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/ijc.22592","article-title":"Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples","volume":"120","author":"Kjaerheim","year":"2007","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2007.12.025_bib51","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/00365510152567077","article-title":"Effect of long-term storage on the concentration of albumin and free fatty acids in human sera","volume":"61","author":"Hostmark","year":"2001","journal-title":"Scand J Clin Lab Invest"},{"issue":"3B","key":"10.1016\/j.lungcan.2007.12.025_bib52","first-page":"2369","article-title":"A profile of tumor markers in the population of Kuwait","volume":"19","author":"al-Sayer","year":"1999","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.lungcan.2007.12.025_bib53","first-page":"67","volume":"17","author":"Behbehani","year":"2002","journal-title":"Int J Biol Markers"},{"issue":"2","key":"10.1016\/j.lungcan.2007.12.025_bib54","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/1078-0432.CCR-05-1477","article-title":"Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer","volume":"12","author":"Hassan","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.lungcan.2007.12.025_bib55","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bpobgyn.2005.10.012","article-title":"Screening for ovarian cancer in the general population","volume":"20","author":"Chu","year":"2006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"15","key":"10.1016\/j.lungcan.2007.12.025_bib56","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","article-title":"Asbestos exposure, pleural mesothelioma, and serum osteopontin levels","volume":"353","author":"Pass","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2007.12.025_bib57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2407-5-83","article-title":"Application of serum SELDI proteomic patterns in diagnosis of lung cancer","volume":"5","author":"Yang","year":"2005","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2007.12.025_bib58","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.93.1.136","article-title":"Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers","volume":"93","author":"Chang","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3B","key":"10.1016\/j.lungcan.2007.12.025_bib59","first-page":"2435","article-title":"Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells","volume":"23","author":"Dobra","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.lungcan.2007.12.025_bib60","doi-asserted-by":"crossref","unstructured":"Scherpereel A, Grigoriu BD, Conti M, Gey T, Gregoire M, Copin MC, et al. Soluble mesothelin-related protein in the diagnosis of malignant pleural mesothelioma. Am J Respir Crit Care Med; February 2, 2006.","DOI":"10.1164\/rccm.200511-1789OC"},{"issue":"3 Pt 1","key":"10.1016\/j.lungcan.2007.12.025_bib61","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1158\/1078-0432.CCR-05-1397","article-title":"Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma","volume":"12","author":"Yen","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.lungcan.2007.12.025_bib62","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/cncr.10209","article-title":"Diffuse malignant epithelial mesotheliomas of the peritoneum in women: a clinicopathologic study of 25 patients","volume":"94","author":"Kerrigan","year":"2002","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2007.12.025_bib63","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1440-1827.2007.02080.x","article-title":"Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma","volume":"57","author":"Kushitani","year":"2007","journal-title":"Pathol Int"},{"issue":"12 Pt 1","key":"10.1016\/j.lungcan.2007.12.025_bib64","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1158\/1078-0432.CCR-03-0801","article-title":"Mesothelin: a new target for immunotherapy","volume":"10","author":"Hassan","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.lungcan.2007.12.025_bib65","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1021\/bc060314x","article-title":"Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in mice","volume":"18","author":"Filpula","year":"2007","journal-title":"Bioconjug Chem"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500208000032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500208000032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:18:53Z","timestamp":1759234733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500208000032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0169500208000032"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2007.12.025","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesothelin-related predictive and prognostic factors in malignant mesothelioma: A nested case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2007.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}